tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Johnson & Johnson price target raised to $176 from $171 at Morgan Stanley

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Johnson & Johnson to $176 from $171 and keeps an Equal Weight rating on the shares. The firm cites the company’s Q2 earnings beat and expectations for top and bottom line growth in 2026 but also notes limited visibility on potential pharma tariffs and Most Favored Nation drug pricing policy, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1